Treatment of Seasonal or Perennial Allergic Conjunctivitis
Patients with a confirmed diagnosis of seasonal or perennial allergic conjunctivitis require a structured topical treatment regimen. A range of topical medications is available for this population, and the approach is tailored to symptom pattern and response.
Clinical Scenario
This protocol applies to patients in whom seasonal or perennial allergic conjunctivitis has been established as the diagnosis. Topical therapy is the primary route of management, with agent selection guided by symptom severity and individual tolerability.
Treatment Approach
When symptoms are not adequately controlled, a short course of a topical corticosteroid selected for its low side-effect profile may be added to the existing regimen. Alongside this, cooled artificial tears may help address any coexisting tear deficiency and reduce allergen and inflammatory mediator load on the ocular surface.
The complete agent selection, dosing schedule, and stepwise algorithm are detailed in the full structured protocol.
References
- Table 2 lists topical medications that can be used for seasonal allergic conjunctivitis.
- If the symptoms are not adequately controlled, a brief course (1 to 2 weeks) of topical corticosteroids with a low side effect profile can be added to the regimen.
- Concomitant use of cooled artificial tears may alleviate coexisting tear deficiency and dilute allergens and inflammatory mediators on the ocular surface.